rs2506991
From SNPedia
Orientation | minus |
Stabilized | minus |
Make rs2506991(C;C) |
Make rs2506991(C;T) |
Make rs2506991(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 1 |
Position | 47632734 |
is a | snp |
is | mentioned by |
dbSNP | rs2506991 |
dbSNP (classic) | rs2506991 |
ClinGen | rs2506991 |
ebi | rs2506991 |
HLI | rs2506991 |
Exac | rs2506991 |
Gnomad | rs2506991 |
Varsome | rs2506991 |
LitVar | rs2506991 |
Map | rs2506991 |
PheGenI | rs2506991 |
Biobank | rs2506991 |
1000 genomes | rs2506991 |
hgdp | rs2506991 |
ensembl | rs2506991 |
geneview | rs2506991 |
scholar | rs2506991 |
rs2506991 | |
pharmgkb | rs2506991 |
gwascentral | rs2506991 |
openSNP | rs2506991 |
23andMe | rs2506991 |
SNPshot | rs2506991 |
SNPdbe | rs2506991 |
MSV3d | rs2506991 |
GWAS Ctlg | rs2506991 |
GMAF | 0.461 |
Max Magnitude | 0 |
? | (C;C) (C;T) (T;T) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23648065![]() |
Trait | Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide) |
Title | Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. |
Risk Allele | G |
P-val | 2E-6 |
Odds Ratio | 3.95 [2.101-7.418] |